About the journal
Cellular Oncology is a journal published by Springer Nature in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,190 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 2211-3428 · 2211-3436
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 4,190 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/13402
Index listings
- MEDLINE · 2010-01-01
- Indexing
- MEDLINE
- APC
- 4,190 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 122 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1202
Last recorded publication year
2026
h-index
74
i10-index
727
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 85%
- ORCID iDs in current deposits
- 19%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101552938
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Ferroptosis and cancer prognosis
- Cancer, Hypoxia, and Metabolism
Show all subjects (75)
- Cancer, Hypoxia, and Metabolism
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Cancer Immunotherapy and Biomarkers
- Immune cells in cancer
- Immune cells in cancer
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Epigenetics and DNA Methylation
- Hepatocellular Carcinoma Treatment and Prognosis
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Pancreatic and Hepatic Oncology Research
- Epigenetics and DNA Methylation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Head and Neck Cancer Studies
- Epigenetics and DNA Methylation
- Glioma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Cancer-related Molecular Pathways
- Mechanisms of cancer metastasis
- Immune cells in cancer
- Gastric Cancer Management and Outcomes
- Cancer, Lipids, and Metabolism
- Colorectal Cancer Treatments and Studies
- Ferroptosis and cancer prognosis
- RNA modifications and cancer
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Circular RNAs in diseases
- Circular RNAs in diseases
- Lung Cancer Treatments and Mutations
- Immunotherapy and Immune Responses
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Lung Cancer Research Studies
- Cancer Research and Treatments
- Wnt/β-catenin signaling in development and cancer
- TGF-β signaling in diseases
- Immunotherapy and Immune Responses
- RNA modifications and cancer
- Wnt/β-catenin signaling in development and cancer
- Cancer, Stress, Anesthesia, and Immune Response
- Immunotherapy and Immune Responses
- Cancer, Stress, Anesthesia, and Immune Response
- Cancer Research and Treatments
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Glycosylation and Glycoproteins Research
- Autophagy in Disease and Therapy
- Glycosylation and Glycoproteins Research
- Cancer, Lipids, and Metabolism
- Autophagy in Disease and Therapy
- Ubiquitin and proteasome pathways
- Single-cell and spatial transcriptomics
- Ubiquitin and proteasome pathways
- Glioma Diagnosis and Treatment
- Extracellular vesicles in disease
- Single-cell and spatial transcriptomics
- Extracellular vesicles in disease
- Histone Deacetylase Inhibitors Research
- Glioma Diagnosis and Treatment
- Histone Deacetylase Inhibitors Research
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ